作为料添加剂的N-乙半氨酸可以抵消禽类中甲毒素A的毒性
Muntaha Tanveer1,2, Muhammad Imran2, Muhammad Kashif Saleemi2
1Department of Zoology, Wildlife and Fisheries, Faculty of Sciences, University of Agriculture, Faisalabad, Pakistan.
概括
N-乙半氨酸 (NAC) 有效地保护肉免受Ochratoxin A (OTA) 毒性的影响. 补充NAC改善了生长,器官功能,并减少了由这种常见的家禽料污染物引起的组织损伤.
科学领域:
- 兽医毒理学 兽医毒理学
- 动物营养 动物营养
- 食品安全 食品安全
背景情况:
- 毒素A (OTA) 是一种污染家禽料的真菌毒素,对肉的健康和表现产生负面影响.
- 暴露于OTA会导致的显著生长障碍,免疫功能障碍和器官损伤.
- N-乙半氨酸 (NAC) 是一种抗氧化剂和谷氨前体,具有潜在的保护性质.
研究的目的:
- 评估N-乙半氨酸 (NAC) 在减轻Ochratoxin A (OTA) 诱导的肉中毒性的疗效.
- 评估NAC对与OTA暴露相关的临床病理学和组织病理学变化的影响.
- 为了比较NAC与商业毒素结合剂的保护作用.
主要方法:
- 125只肉被分为五组:对照组,OTA,NAC,OTA+NAC和OTA+毒素结合剂.
- 鸟类暴露于OTA (400μg/kg) 或补充NAC (100 mg/kg) 或毒素结合剂五周.
- 评估的参数包括临床症状,食摄入量,体重,血清生物化学和粗体/组织病理性病变.
主要成果:
- 暴露于OTA显著减少了料摄入量,体重增加和血清蛋白质.
- 肝脏和脏酶标记物 (ALT,AST,尿素,肌素) 的升高表明肝脏和脏受损严重.
- 补充NAC有效抵消了OTA的不良影响,恢复了性能和器官健康,与毒素结合剂相当.
结论:
- N-乙半氨酸 (NAC) 在 brojler中显示出显著的保护作用,防止Ochratoxin A (OTA) 毒性.
- NAC可以成为一种有价值,具有成本效益的料添加剂,用于预防家禽中与真菌毒素相关的健康问题.
- 进一步研究NAC在家禽料安全方面的作用是有必要的.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Antidotes
757
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
757
Prevention of Further Absorption of Poison
925
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
925
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
830
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
830
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K


